Katri Vaparanta

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Subarachnoid Hemorrhage

Small Cell Lung Cancer

Top Venues

The Journal of biological chemistry

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Katri Vaparanta, Anne Jokilammi, Ilkka Paatero, Johannes A M Merilahti, Juho Heliste, Karthik Amudhala Hemanthakumar, Riikka Kivelä, Kari Alitalo, Pekka Taimen, Klaus Elenius
STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth. EMBO reports (2023)
Katri Vaparanta, Anne Jokilammi, Mahlet Tamirat, Johannes A M Merilahti, Kari Salokas, Markku Varjosalo, Johanna Ivaska, Mark S Johnson, Klaus Elenius
An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation. Nature communications 13 (1) (2022)
Veera K Ojala, Anna M Knittle, Peppi Kirjalainen, Johannes A M Merilahti, Maarit Kortesoja, Denis Tvorogov, Katri Vaparanta, Shujun Lin, Jürgen Kast, Arto T Pulliainen, Kari J Kurppa, Klaus Elenius
The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration. The Journal of biological chemistry 295 (33) (2020)